
Kelly K Hunt MD
Surgical Oncology (Other than Breast)
Professor of Surgery, University Tex Houston
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Hunt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1986 - 1993
- University of Tennessee Health Science Center College of MedicineClass of 1986
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2027
- GA State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- AL State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- MS State Medical License 2023 - 2025
- American Board of Surgery Surgery
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2007 Jul 01
- A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer Start of enrollment: 2019 Aug 09
- A Study of LY3484356 in Women With Breast Cancer Before Having Surgery Start of enrollment: 2021 Apr 21
Publications & Presentations
PubMed
- Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical Trial.Henry M Kuerer, Vicente Valero, Benjamin D Smith, Savitri Krishnamurthy, Emilia J Diego
JAMA Oncology. 2025-03-28 - Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.Zhan Xu, Zijian Zhou, Jong Bum Son, Haonan Feng, Beatriz E Adrada
Cancers. 2025-03-13 - Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer.Linjie Luo, Peng Yang, Sofia Mastoraki, Xiayu Rao, Yan Wang
Molecular Cancer. 2025-02-15
Journal Articles
- OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer PatientsI Bedrosian, K K Hunt, A Lucci, D M Black, H M Kuerer, M Teshome, A S Caudle, S M DeSnyder, R F Hwang, Annals of Surgical Oncology
- Incorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging SystemKelly K Hunt, Tari A King, Anna Weiss, The Surgical Clinics of North America
- The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) TrialKelly K Hunt, Armando Giuliano, Judy C Boughey, Laurie Cuttino, Kari M Rosenkranz, Bruce Haffty, Annals of Surgical Oncology
- Join now to see all
Press Mentions
- Surgical vs Neoadjuvant Therapy: A Lively Debate Among Experts Opens Miami Breast Cancer Conference 2025March 6th, 2025
- FDA Panel Backs Cryoablation in Early Breast Cancer as Alternative to SurgeryNovember 8th, 2024
- What Not to Say to Someone Who Got a MastectomyOctober 26th, 2022
- Join now to see all
Grant Support
- UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1UNIVERSITY OF TX MD ANDERSON CAN CTR2019–2025
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: